ICU Medical, Inc. (ICUI)
USD 154.07
(-1.97%)
USD 154.07
(-1.97%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 717.04 Million USD | -4.45% |
| 2022 | 701.32 Million USD | 100.26% |
| 2021 | 350.2 Million USD | 7.45% |
| 2020 | 325.92 Million USD | -1.63% |
| 2019 | 331.33 Million USD | -13.04% |
| 2018 | 381.01 Million USD | 7.27% |
| 2017 | 355.2 Million USD | 246.95% |
| 2016 | 102.38 Million USD | 3.49% |
| 2015 | 98.93 Million USD | -7.78% |
| 2014 | 107.27 Million USD | 4.37% |
| 2013 | 102.78 Million USD | 7.93% |
| 2012 | 95.23 Million USD | 1.45% |
| 2011 | 93.87 Million USD | 15.45% |
| 2010 | 81.31 Million USD | 14.77% |
| 2009 | 70.85 Million USD | 21.25% |
| 2008 | 58.43 Million USD | 9.03% |
| 2007 | 53.59 Million USD | 7.6% |
| 2006 | 49.81 Million USD | 19.14% |
| 2005 | 41.8 Million USD | 40.37% |
| 2004 | 29.78 Million USD | 20.17% |
| 2003 | 24.78 Million USD | 16.13% |
| 2002 | 21.34 Million USD | 18.55% |
| 2001 | 18 Million USD | -11.72% |
| 2000 | 20.39 Million USD | 15.88% |
| 1999 | 17.6 Million USD | 13.55% |
| 1998 | 15.5 Million USD | 30.25% |
| 1997 | 11.9 Million USD | 16.67% |
| 1996 | 10.2 Million USD | 37.84% |
| 1995 | 7.4 Million USD | 48.0% |
| 1994 | 5 Million USD | 51.52% |
| 1993 | 3.3 Million USD | 32.0% |
| 1992 | 2.5 Million USD | 92.31% |
| 1991 | 1.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 182.93 Million USD | 11.27% |
| 2024 Q1 | 179.49 Million USD | 1.4% |
| 2023 FY | 670.12 Million USD | -4.45% |
| 2023 Q1 | 172.33 Million USD | 3.58% |
| 2023 Q4 | 177.02 Million USD | 4.45% |
| 2023 Q3 | 169.47 Million USD | -2.15% |
| 2023 Q2 | 173.19 Million USD | 0.5% |
| 2022 Q2 | 181.31 Million USD | 2.39% |
| 2022 FY | 701.32 Million USD | 100.26% |
| 2022 Q4 | 166.37 Million USD | -5.76% |
| 2022 Q3 | 176.55 Million USD | -2.62% |
| 2022 Q1 | 177.08 Million USD | 87.15% |
| 2021 Q2 | 85.3 Million USD | 2.5% |
| 2021 Q3 | 87.05 Million USD | 2.05% |
| 2021 FY | 350.2 Million USD | 7.45% |
| 2021 Q4 | 94.62 Million USD | 8.69% |
| 2021 Q1 | 83.22 Million USD | -2.49% |
| 2020 FY | 325.92 Million USD | -1.63% |
| 2020 Q1 | 83.05 Million USD | -2.47% |
| 2020 Q2 | 77.54 Million USD | -6.63% |
| 2020 Q3 | 79.98 Million USD | 3.14% |
| 2020 Q4 | 85.34 Million USD | 6.71% |
| 2019 Q3 | 77.87 Million USD | -2.73% |
| 2019 Q4 | 85.15 Million USD | 9.34% |
| 2019 Q2 | 80.06 Million USD | -9.27% |
| 2019 FY | 331.33 Million USD | -13.04% |
| 2019 Q1 | 88.23 Million USD | -5.19% |
| 2018 Q4 | 93.06 Million USD | 1.99% |
| 2018 Q1 | 99.58 Million USD | 9.41% |
| 2018 Q2 | 97.11 Million USD | -2.48% |
| 2018 Q3 | 91.24 Million USD | -6.04% |
| 2018 FY | 381.01 Million USD | 7.27% |
| 2017 Q1 | 76.52 Million USD | 203.05% |
| 2017 Q4 | 91.01 Million USD | 1.59% |
| 2017 Q3 | 89.58 Million USD | -8.65% |
| 2017 Q2 | 98.07 Million USD | 28.15% |
| 2017 FY | 355.2 Million USD | 246.95% |
| 2016 Q2 | 25.82 Million USD | 2.14% |
| 2016 FY | 102.38 Million USD | 3.49% |
| 2016 Q4 | 25.25 Million USD | -2.92% |
| 2016 Q3 | 26.01 Million USD | 0.71% |
| 2016 Q1 | 25.28 Million USD | -4.85% |
| 2015 FY | 98.93 Million USD | -7.78% |
| 2015 Q4 | 26.57 Million USD | 8.77% |
| 2015 Q1 | 24.48 Million USD | -3.53% |
| 2015 Q3 | 24.43 Million USD | 4.24% |
| 2015 Q2 | 23.44 Million USD | -4.26% |
| 2014 Q3 | 26.89 Million USD | -6.75% |
| 2014 FY | 107.27 Million USD | 4.37% |
| 2014 Q1 | 26.15 Million USD | 3.01% |
| 2014 Q2 | 28.84 Million USD | 10.3% |
| 2014 Q4 | 25.37 Million USD | -5.65% |
| 2013 Q4 | 25.38 Million USD | -0.6% |
| 2013 Q3 | 25.53 Million USD | -5.72% |
| 2013 Q2 | 27.08 Million USD | 9.36% |
| 2013 Q1 | 24.76 Million USD | 7.92% |
| 2013 FY | 102.78 Million USD | 7.93% |
| 2012 FY | 95.23 Million USD | 1.45% |
| 2012 Q2 | 25.53 Million USD | 8.28% |
| 2012 Q3 | 23.16 Million USD | -9.28% |
| 2012 Q4 | 22.95 Million USD | -0.92% |
| 2012 Q1 | 23.58 Million USD | -3.55% |
| 2011 Q2 | 22.22 Million USD | -0.87% |
| 2011 FY | 93.87 Million USD | 15.45% |
| 2011 Q4 | 24.45 Million USD | 9.7% |
| 2011 Q3 | 22.28 Million USD | 0.3% |
| 2011 Q1 | 22.41 Million USD | 6.69% |
| 2010 Q1 | 20.57 Million USD | 0.51% |
| 2010 Q4 | 21 Million USD | 8.25% |
| 2010 FY | 81.31 Million USD | 14.77% |
| 2010 Q3 | 19.4 Million USD | -4.51% |
| 2010 Q2 | 20.32 Million USD | -1.21% |
| 2009 Q4 | 20.46 Million USD | 17.55% |
| 2009 FY | 70.85 Million USD | 21.25% |
| 2009 Q1 | 15.85 Million USD | 15.35% |
| 2009 Q2 | 17.12 Million USD | 8.01% |
| 2009 Q3 | 17.41 Million USD | 1.71% |
| 2008 FY | 58.43 Million USD | 9.03% |
| 2008 Q4 | 13.74 Million USD | -4.76% |
| 2008 Q2 | 15.13 Million USD | 0.07% |
| 2008 Q1 | 15.12 Million USD | 22.32% |
| 2008 Q3 | 14.42 Million USD | -4.68% |
| 2007 Q2 | 13.65 Million USD | -1.38% |
| 2007 FY | 53.59 Million USD | 7.6% |
| 2007 Q1 | 13.85 Million USD | 11.05% |
| 2007 Q4 | 12.36 Million USD | -9.85% |
| 2007 Q3 | 13.71 Million USD | 0.44% |
| 2006 Q1 | 12.16 Million USD | 5.61% |
| 2006 Q3 | 10.6 Million USD | -27.2% |
| 2006 Q4 | 12.47 Million USD | 17.57% |
| 2006 FY | 49.81 Million USD | 19.14% |
| 2006 Q2 | 14.57 Million USD | 19.83% |
| 2005 Q2 | 10.61 Million USD | 22.0% |
| 2005 FY | 41.8 Million USD | 40.37% |
| 2005 Q4 | 11.51 Million USD | 4.79% |
| 2005 Q1 | 8.69 Million USD | 7.33% |
| 2005 Q3 | 10.98 Million USD | 3.56% |
| 2004 Q2 | 7 Million USD | 14.74% |
| 2004 Q3 | 8.57 Million USD | 22.32% |
| 2004 Q1 | 6.1 Million USD | -3.72% |
| 2004 FY | 29.78 Million USD | 20.17% |
| 2004 Q4 | 8.1 Million USD | -5.45% |
| 2003 Q1 | 6.55 Million USD | 33.51% |
| 2003 FY | 24.78 Million USD | 16.13% |
| 2003 Q4 | 6.34 Million USD | 9.23% |
| 2003 Q2 | 6.08 Million USD | -7.29% |
| 2003 Q3 | 5.8 Million USD | -4.51% |
| 2002 Q2 | 5.76 Million USD | 3.97% |
| 2002 FY | 21.34 Million USD | 18.55% |
| 2002 Q4 | 4.91 Million USD | -4.19% |
| 2002 Q3 | 5.12 Million USD | -11.02% |
| 2002 Q1 | 5.54 Million USD | 5.72% |
| 2001 Q3 | 4.52 Million USD | -0.7% |
| 2001 Q2 | 4.56 Million USD | -4.26% |
| 2001 Q4 | 5.24 Million USD | 15.77% |
| 2001 Q1 | 4.76 Million USD | -14.49% |
| 2001 FY | 18 Million USD | -11.72% |
| 2000 Q2 | 5.04 Million USD | -5.76% |
| 2000 Q4 | 5.57 Million USD | 38.21% |
| 2000 FY | 20.39 Million USD | 15.88% |
| 2000 Q1 | 5.34 Million USD | 2.87% |
| 2000 Q3 | 4.03 Million USD | -20.06% |
| 1999 Q4 | 5.2 Million USD | 30.0% |
| 1999 Q2 | 4.2 Million USD | 0.0% |
| 1999 FY | 17.6 Million USD | 13.55% |
| 1999 Q3 | 4 Million USD | -4.76% |
| 1999 Q1 | 4.2 Million USD | 23.53% |
| 1998 Q3 | 3.8 Million USD | -11.63% |
| 1998 Q1 | 4.1 Million USD | 24.24% |
| 1998 FY | 15.5 Million USD | 30.25% |
| 1998 Q4 | 3.4 Million USD | -10.53% |
| 1998 Q2 | 4.3 Million USD | 4.88% |
| 1997 Q3 | 3 Million USD | 3.45% |
| 1997 Q2 | 2.9 Million USD | 11.54% |
| 1997 Q1 | 2.6 Million USD | -29.73% |
| 1997 FY | 11.9 Million USD | 16.67% |
| 1997 Q4 | 3.3 Million USD | 10.0% |
| 1996 Q2 | 2.2 Million USD | 10.0% |
| 1996 FY | 10.2 Million USD | 37.84% |
| 1996 Q3 | 2.4 Million USD | 9.09% |
| 1996 Q4 | 3.7 Million USD | 54.17% |
| 1996 Q1 | 2 Million USD | 11.11% |
| 1995 Q3 | 1.5 Million USD | -31.82% |
| 1995 Q4 | 1.8 Million USD | 20.0% |
| 1995 Q2 | 2.2 Million USD | 22.22% |
| 1995 FY | 7.4 Million USD | 48.0% |
| 1995 Q1 | 1.8 Million USD | 28.57% |
| 1994 FY | 5 Million USD | 51.52% |
| 1994 Q1 | 1 Million USD | 11.11% |
| 1994 Q2 | 1.1 Million USD | 10.0% |
| 1994 Q3 | 1.3 Million USD | 18.18% |
| 1994 Q4 | 1.4 Million USD | 7.69% |
| 1993 FY | 3.3 Million USD | 32.0% |
| 1993 Q4 | 900 Thousand USD | 12.5% |
| 1993 Q3 | 800 Thousand USD | -11.11% |
| 1993 Q2 | 900 Thousand USD | 28.57% |
| 1993 Q1 | 700 Thousand USD | -12.5% |
| 1992 Q1 | 400 Thousand USD | 111.43% |
| 1992 Q2 | 600 Thousand USD | 50.0% |
| 1992 Q3 | 600 Thousand USD | 0.0% |
| 1992 Q4 | 800 Thousand USD | 33.33% |
| 1992 FY | 2.5 Million USD | 92.31% |
| 1991 Q1 | - USD | 0.0% |
| 1991 FY | 1.3 Million USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | -3.5 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | -587.684% |
| AngioDynamics, Inc. | 252.41 Million USD | -184.074% |
| AtriCure, Inc. | 327.05 Million USD | -119.245% |
| Avinger, Inc. | 18.63 Million USD | -3747.237% |
| Azenta, Inc. | 336.26 Million USD | -113.238% |
| BioLife Solutions, Inc. | 117.57 Million USD | -509.854% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 60.705% |
| Daxor Corporation | 1.28 Million USD | -55896.845% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -2864.111% |
| Femasys Inc. | 15.2 Million USD | -4617.323% |
| GlucoTrack, Inc. | 7.1 Million USD | -9993.581% |
| Harvard Bioscience, Inc. | 58.58 Million USD | -1124.028% |
| Hologic, Inc. | 1.34 Billion USD | 46.696% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 75.797% |
| KORU Medical Systems, Inc. | 26.1 Million USD | -2646.482% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | -693.748% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 601000.033% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 601000.033% |
| Masimo Corporation | 867 Million USD | 17.296% |
| Microbot Medical Inc. | 9.85 Million USD | -7175.982% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -3792.755% |
| Merit Medical Systems, Inc. | 459.92 Million USD | -55.904% |
| Nephros, Inc. | 9.78 Million USD | -7228.782% |
| NovoCure Limited | 613.92 Million USD | -16.797% |
| NEXGEL, Inc. | 4.09 Million USD | -17406.055% |
| NEXGEL, Inc. | 4.09 Million USD | -17406.055% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | -601.317% |
| OraSure Technologies, Inc. | 125.34 Million USD | -472.073% |
| Pro-Dex, Inc. | 7.37 Million USD | -9618.731% |
| Pulse Biosciences, Inc. | 43.57 Million USD | -1545.587% |
| Predictive Oncology Inc. | 15.22 Million USD | -4608.274% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -8313.973% |
| QuidelOrtho Corporation | 1.35 Billion USD | 47.093% |
| Repligen Corporation | 261.12 Million USD | -174.602% |
| Sanara MedTech Inc. | 61.12 Million USD | -1073.043% |
| STAAR Surgical Company | 224.55 Million USD | -219.321% |
| Sharps Technology, Inc. | 10.12 Million USD | -6980.802% |
| Utah Medical Products, Inc. | 13.26 Million USD | -5307.194% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 60.031% |
| Jin Medical International Ltd. | 3.91 Million USD | -18203.378% |